Global Oxcarbazepine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oxcarbazepine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oxcarbazepine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oxcarbazepine by Country/Region, 2017, 2022 & 2028

2.2 Oxcarbazepine Segment by Type

2.2.1 Tablets (150mg, 300mg, 600mg)

2.2.2 Oral Suspension

2.3 Oxcarbazepine Sales by Type

2.3.1 Global Oxcarbazepine Sales Market Share by Type (2017-2022)

2.3.2 Global Oxcarbazepine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oxcarbazepine Sale Price by Type (2017-2022)

2.4 Oxcarbazepine Segment by Application

2.4.1 Pediatric Use (Aged 2-4 years, 4-16 years)

2.4.2 Adult Use

2.5 Oxcarbazepine Sales by Application

2.5.1 Global Oxcarbazepine Sale Market Share by Application (2017-2022)

2.5.2 Global Oxcarbazepine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oxcarbazepine Sale Price by Application (2017-2022)

3 Global Oxcarbazepine by Company

3.1 Global Oxcarbazepine Breakdown Data by Company

3.1.1 Global Oxcarbazepine Annual Sales by Company (2020-2022)

3.1.2 Global Oxcarbazepine Sales Market Share by Company (2020-2022)

3.2 Global Oxcarbazepine Annual Revenue by Company (2020-2022)

3.2.1 Global Oxcarbazepine Revenue by Company (2020-2022)

3.2.2 Global Oxcarbazepine Revenue Market Share by Company (2020-2022)

3.3 Global Oxcarbazepine Sale Price by Company

3.4 Key Manufacturers Oxcarbazepine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oxcarbazepine Product Location Distribution

3.4.2 Players Oxcarbazepine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oxcarbazepine by Geographic Region

4.1 World Historic Oxcarbazepine Market Size by Geographic Region (2017-2022)

4.1.1 Global Oxcarbazepine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oxcarbazepine Annual Revenue by Geographic Region

4.2 World Historic Oxcarbazepine Market Size by Country/Region (2017-2022)

4.2.1 Global Oxcarbazepine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oxcarbazepine Annual Revenue by Country/Region

4.3 Americas Oxcarbazepine Sales Growth

4.4 APAC Oxcarbazepine Sales Growth

4.5 Europe Oxcarbazepine Sales Growth

4.6 Middle East & Africa Oxcarbazepine Sales Growth

5 Americas

5.1 Americas Oxcarbazepine Sales by Country

5.1.1 Americas Oxcarbazepine Sales by Country (2017-2022)

5.1.2 Americas Oxcarbazepine Revenue by Country (2017-2022)

5.2 Americas Oxcarbazepine Sales by Type

5.3 Americas Oxcarbazepine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oxcarbazepine Sales by Region

6.1.1 APAC Oxcarbazepine Sales by Region (2017-2022)

6.1.2 APAC Oxcarbazepine Revenue by Region (2017-2022)

6.2 APAC Oxcarbazepine Sales by Type

6.3 APAC Oxcarbazepine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oxcarbazepine by Country

7.1.1 Europe Oxcarbazepine Sales by Country (2017-2022)

7.1.2 Europe Oxcarbazepine Revenue by Country (2017-2022)

7.2 Europe Oxcarbazepine Sales by Type

7.3 Europe Oxcarbazepine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oxcarbazepine by Country

8.1.1 Middle East & Africa Oxcarbazepine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oxcarbazepine Revenue by Country (2017-2022)

8.2 Middle East & Africa Oxcarbazepine Sales by Type

8.3 Middle East & Africa Oxcarbazepine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oxcarbazepine

10.3 Manufacturing Process Analysis of Oxcarbazepine

10.4 Industry Chain Structure of Oxcarbazepine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oxcarbazepine Distributors

11.3 Oxcarbazepine Customer

12 World Forecast Review for Oxcarbazepine by Geographic Region

12.1 Global Oxcarbazepine Market Size Forecast by Region

12.1.1 Global Oxcarbazepine Forecast by Region (2023-2028)

12.1.2 Global Oxcarbazepine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oxcarbazepine Forecast by Type

12.7 Global Oxcarbazepine Forecast by Application

13 Key Players Analysis

13.1 Novartis (Trileptal)

13.1.1 Novartis (Trileptal) Company Information

13.1.2 Novartis (Trileptal) Oxcarbazepine Product Offered

13.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis (Trileptal) Main Business Overview

13.1.5 Novartis (Trileptal) Latest Developments

13.2 Supernus Pharmaceuticals (Oxtellar XR)

13.2.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information

13.2.2 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Offered

13.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Supernus Pharmaceuticals (Oxtellar XR) Main Business Overview

13.2.5 Supernus Pharmaceuticals (Oxtellar XR) Latest Developments

13.3 Sun Pharm

13.3.1 Sun Pharm Company Information

13.3.2 Sun Pharm Oxcarbazepine Product Offered

13.3.3 Sun Pharm Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sun Pharm Main Business Overview

13.3.5 Sun Pharm Latest Developments

13.4 Ranbaxy Pharmaceuticals

13.4.1 Ranbaxy Pharmaceuticals Company Information

13.4.2 Ranbaxy Pharmaceuticals Oxcarbazepine Product Offered

13.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ranbaxy Pharmaceuticals Main Business Overview

13.4.5 Ranbaxy Pharmaceuticals Latest Developments

13.5 Jubilant Generics

13.5.1 Jubilant Generics Company Information

13.5.2 Jubilant Generics Oxcarbazepine Product Offered

13.5.3 Jubilant Generics Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Jubilant Generics Main Business Overview

13.5.5 Jubilant Generics Latest Developments

13.6 Taro Pharmaceuticals

13.6.1 Taro Pharmaceuticals Company Information

13.6.2 Taro Pharmaceuticals Oxcarbazepine Product Offered

13.6.3 Taro Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Taro Pharmaceuticals Main Business Overview

13.6.5 Taro Pharmaceuticals Latest Developments

13.7 Mylan

13.7.1 Mylan Company Information

13.7.2 Mylan Oxcarbazepine Product Offered

13.7.3 Mylan Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mylan Main Business Overview

13.7.5 Mylan Latest Developments

13.8 Stada Group

13.8.1 Stada Group Company Information

13.8.2 Stada Group Oxcarbazepine Product Offered

13.8.3 Stada Group Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Stada Group Main Business Overview

13.8.5 Stada Group Latest Developments

13.9 Glenmark Pharmaceuticals

13.9.1 Glenmark Pharmaceuticals Company Information

13.9.2 Glenmark Pharmaceuticals Oxcarbazepine Product Offered

13.9.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Glenmark Pharmaceuticals Main Business Overview

13.9.5 Glenmark Pharmaceuticals Latest Developments

13.10 ANI Pharmaceuticals

13.10.1 ANI Pharmaceuticals Company Information

13.10.2 ANI Pharmaceuticals Oxcarbazepine Product Offered

13.10.3 ANI Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 ANI Pharmaceuticals Main Business Overview

13.10.5 ANI Pharmaceuticals Latest Developments

13.11 Teva Pharmaceutical

13.11.1 Teva Pharmaceutical Company Information

13.11.2 Teva Pharmaceutical Oxcarbazepine Product Offered

13.11.3 Teva Pharmaceutical Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Teva Pharmaceutical Main Business Overview

13.11.5 Teva Pharmaceutical Latest Developments

13.12 Roxane Laboratories

13.12.1 Roxane Laboratories Company Information

13.12.2 Roxane Laboratories Oxcarbazepine Product Offered

13.12.3 Roxane Laboratories Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Roxane Laboratories Main Business Overview

13.12.5 Roxane Laboratories Latest Developments

13.13 Nobelpharma

13.13.1 Nobelpharma Company Information

13.13.2 Nobelpharma Oxcarbazepine Product Offered

13.13.3 Nobelpharma Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Nobelpharma Main Business Overview

13.13.5 Nobelpharma Latest Developments

13.14 Apotex

13.14.1 Apotex Company Information

13.14.2 Apotex Oxcarbazepine Product Offered

13.14.3 Apotex Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Apotex Main Business Overview

13.14.5 Apotex Latest Developments

13.15 Nexgen pharma

13.15.1 Nexgen pharma Company Information

13.15.2 Nexgen pharma Oxcarbazepine Product Offered

13.15.3 Nexgen pharma Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Nexgen pharma Main Business Overview

13.15.5 Nexgen pharma Latest Developments

13.16 Amneal Pharmaceuticals

13.16.1 Amneal Pharmaceuticals Company Information

13.16.2 Amneal Pharmaceuticals Oxcarbazepine Product Offered

13.16.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Amneal Pharmaceuticals Main Business Overview

13.16.5 Amneal Pharmaceuticals Latest Developments

13.17 Hikma Pharmaceuticals

13.17.1 Hikma Pharmaceuticals Company Information

13.17.2 Hikma Pharmaceuticals Oxcarbazepine Product Offered

13.17.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Hikma Pharmaceuticals Main Business Overview

13.17.5 Hikma Pharmaceuticals Latest Developments

13.18 Jamp Pharma

13.18.1 Jamp Pharma Company Information

13.18.2 Jamp Pharma Oxcarbazepine Product Offered

13.18.3 Jamp Pharma Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Jamp Pharma Main Business Overview

13.18.5 Jamp Pharma Latest Developments

13.19 Neuraxpharm

13.19.1 Neuraxpharm Company Information

13.19.2 Neuraxpharm Oxcarbazepine Product Offered

13.19.3 Neuraxpharm Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Neuraxpharm Main Business Overview

13.19.5 Neuraxpharm Latest Developments

13.20 Orion Corporation

13.20.1 Orion Corporation Company Information

13.20.2 Orion Corporation Oxcarbazepine Product Offered

13.20.3 Orion Corporation Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Orion Corporation Main Business Overview

13.20.5 Orion Corporation Latest Developments

13.21 Sihuan Pharm

13.21.1 Sihuan Pharm Company Information

13.21.2 Sihuan Pharm Oxcarbazepine Product Offered

13.21.3 Sihuan Pharm Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Sihuan Pharm Main Business Overview

13.21.5 Sihuan Pharm Latest Developments

13.22 Humanwell Healthcare

13.22.1 Humanwell Healthcare Company Information

13.22.2 Humanwell Healthcare Oxcarbazepine Product Offered

13.22.3 Humanwell Healthcare Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Humanwell Healthcare Main Business Overview

13.22.5 Humanwell Healthcare Latest Developments

13.23 Huikang Pharmaceutical

13.23.1 Huikang Pharmaceutical Company Information

13.23.2 Huikang Pharmaceutical Oxcarbazepine Product Offered

13.23.3 Huikang Pharmaceutical Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Huikang Pharmaceutical Main Business Overview

13.23.5 Huikang Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Oxcarbazepine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oxcarbazepine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets (150mg, 300mg, 600mg)

Table 4. Major Players of Oral Suspension

Table 5. Global Oxcarbazepine Sales by Type (2017-2022) & (M Unit)

Table 6. Global Oxcarbazepine Sales Market Share by Type (2017-2022)

Table 7. Global Oxcarbazepine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Oxcarbazepine Revenue Market Share by Type (2017-2022)

Table 9. Global Oxcarbazepine Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Oxcarbazepine Sales by Application (2017-2022) & (M Unit)

Table 11. Global Oxcarbazepine Sales Market Share by Application (2017-2022)

Table 12. Global Oxcarbazepine Revenue by Application (2017-2022)

Table 13. Global Oxcarbazepine Revenue Market Share by Application (2017-2022)

Table 14. Global Oxcarbazepine Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Oxcarbazepine Sales by Company (2020-2022) & (M Unit)

Table 16. Global Oxcarbazepine Sales Market Share by Company (2020-2022)

Table 17. Global Oxcarbazepine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Oxcarbazepine Revenue Market Share by Company (2020-2022)

Table 19. Global Oxcarbazepine Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Oxcarbazepine Producing Area Distribution and Sales Area

Table 21. Players Oxcarbazepine Products Offered

Table 22. Oxcarbazepine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Oxcarbazepine Sales by Geographic Region (2017-2022) & (M Unit)

Table 26. Global Oxcarbazepine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Oxcarbazepine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Oxcarbazepine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Oxcarbazepine Sales by Country/Region (2017-2022) & (M Unit)

Table 30. Global Oxcarbazepine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Oxcarbazepine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Oxcarbazepine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Oxcarbazepine Sales by Country (2017-2022) & (M Unit)

Table 34. Americas Oxcarbazepine Sales Market Share by Country (2017-2022)

Table 35. Americas Oxcarbazepine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Oxcarbazepine Revenue Market Share by Country (2017-2022)

Table 37. Americas Oxcarbazepine Sales by Type (2017-2022) & (M Unit)

Table 38. Americas Oxcarbazepine Sales Market Share by Type (2017-2022)

Table 39. Americas Oxcarbazepine Sales by Application (2017-2022) & (M Unit)

Table 40. Americas Oxcarbazepine Sales Market Share by Application (2017-2022)

Table 41. APAC Oxcarbazepine Sales by Region (2017-2022) & (M Unit)

Table 42. APAC Oxcarbazepine Sales Market Share by Region (2017-2022)

Table 43. APAC Oxcarbazepine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Oxcarbazepine Revenue Market Share by Region (2017-2022)

Table 45. APAC Oxcarbazepine Sales by Type (2017-2022) & (M Unit)

Table 46. APAC Oxcarbazepine Sales Market Share by Type (2017-2022)

Table 47. APAC Oxcarbazepine Sales by Application (2017-2022) & (M Unit)

Table 48. APAC Oxcarbazepine Sales Market Share by Application (2017-2022)

Table 49. Europe Oxcarbazepine Sales by Country (2017-2022) & (M Unit)

Table 50. Europe Oxcarbazepine Sales Market Share by Country (2017-2022)

Table 51. Europe Oxcarbazepine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Oxcarbazepine Revenue Market Share by Country (2017-2022)

Table 53. Europe Oxcarbazepine Sales by Type (2017-2022) & (M Unit)

Table 54. Europe Oxcarbazepine Sales Market Share by Type (2017-2022)

Table 55. Europe Oxcarbazepine Sales by Application (2017-2022) & (M Unit)

Table 56. Europe Oxcarbazepine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Oxcarbazepine Sales by Country (2017-2022) & (M Unit)

Table 58. Middle East & Africa Oxcarbazepine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Oxcarbazepine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Oxcarbazepine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Oxcarbazepine Sales by Type (2017-2022) & (M Unit)

Table 62. Middle East & Africa Oxcarbazepine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Oxcarbazepine Sales by Application (2017-2022) & (M Unit)

Table 64. Middle East & Africa Oxcarbazepine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Oxcarbazepine

Table 66. Key Market Challenges & Risks of Oxcarbazepine

Table 67. Key Industry Trends of Oxcarbazepine

Table 68. Oxcarbazepine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Oxcarbazepine Distributors List

Table 71. Oxcarbazepine Customer List

Table 72. Global Oxcarbazepine Sales Forecast by Region (2023-2028) & (M Unit)

Table 73. Global Oxcarbazepine Sales Market Forecast by Region

Table 74. Global Oxcarbazepine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Oxcarbazepine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Oxcarbazepine Sales Forecast by Country (2023-2028) & (M Unit)

Table 77. Americas Oxcarbazepine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Oxcarbazepine Sales Forecast by Region (2023-2028) & (M Unit)

Table 79. APAC Oxcarbazepine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Oxcarbazepine Sales Forecast by Country (2023-2028) & (M Unit)

Table 81. Europe Oxcarbazepine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Oxcarbazepine Sales Forecast by Country (2023-2028) & (M Unit)

Table 83. Middle East & Africa Oxcarbazepine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Oxcarbazepine Sales Forecast by Type (2023-2028) & (M Unit)

Table 85. Global Oxcarbazepine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Oxcarbazepine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Oxcarbazepine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Oxcarbazepine Sales Forecast by Application (2023-2028) & (M Unit)

Table 89. Global Oxcarbazepine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Oxcarbazepine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Oxcarbazepine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novartis (Trileptal) Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 93. Novartis (Trileptal) Oxcarbazepine Product Offered

Table 94. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Novartis (Trileptal) Main Business

Table 96. Novartis (Trileptal) Latest Developments

Table 97. Supernus Pharmaceuticals (Oxtellar XR) Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 98. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Offered

Table 99. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Supernus Pharmaceuticals (Oxtellar XR) Main Business

Table 101. Supernus Pharmaceuticals (Oxtellar XR) Latest Developments

Table 102. Sun Pharm Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 103. Sun Pharm Oxcarbazepine Product Offered

Table 104. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sun Pharm Main Business

Table 106. Sun Pharm Latest Developments

Table 107. Ranbaxy Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 108. Ranbaxy Pharmaceuticals Oxcarbazepine Product Offered

Table 109. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Ranbaxy Pharmaceuticals Main Business

Table 111. Ranbaxy Pharmaceuticals Latest Developments

Table 112. Jubilant Generics Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 113. Jubilant Generics Oxcarbazepine Product Offered

Table 114. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Jubilant Generics Main Business

Table 116. Jubilant Generics Latest Developments

Table 117. Taro Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 118. Taro Pharmaceuticals Oxcarbazepine Product Offered

Table 119. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Taro Pharmaceuticals Main Business

Table 121. Taro Pharmaceuticals Latest Developments

Table 122. Mylan Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 123. Mylan Oxcarbazepine Product Offered

Table 124. Mylan Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Mylan Main Business

Table 126. Mylan Latest Developments

Table 127. Stada Group Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 128. Stada Group Oxcarbazepine Product Offered

Table 129. Stada Group Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Stada Group Main Business

Table 131. Stada Group Latest Developments

Table 132. Glenmark Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 133. Glenmark Pharmaceuticals Oxcarbazepine Product Offered

Table 134. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Glenmark Pharmaceuticals Main Business

Table 136. Glenmark Pharmaceuticals Latest Developments

Table 137. ANI Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 138. ANI Pharmaceuticals Oxcarbazepine Product Offered

Table 139. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. ANI Pharmaceuticals Main Business

Table 141. ANI Pharmaceuticals Latest Developments

Table 142. Teva Pharmaceutical Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 143. Teva Pharmaceutical Oxcarbazepine Product Offered

Table 144. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Teva Pharmaceutical Main Business

Table 146. Teva Pharmaceutical Latest Developments

Table 147. Roxane Laboratories Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 148. Roxane Laboratories Oxcarbazepine Product Offered

Table 149. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Roxane Laboratories Main Business

Table 151. Roxane Laboratories Latest Developments

Table 152. Nobelpharma Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 153. Nobelpharma Oxcarbazepine Product Offered

Table 154. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Nobelpharma Main Business

Table 156. Nobelpharma Latest Developments

Table 157. Apotex Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 158. Apotex Oxcarbazepine Product Offered

Table 159. Apotex Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Apotex Main Business

Table 161. Apotex Latest Developments

Table 162. Nexgen pharma Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 163. Nexgen pharma Oxcarbazepine Product Offered

Table 164. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Nexgen pharma Main Business

Table 166. Nexgen pharma Latest Developments

Table 167. Amneal Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 168. Amneal Pharmaceuticals Oxcarbazepine Product Offered

Table 169. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Amneal Pharmaceuticals Main Business

Table 171. Amneal Pharmaceuticals Latest Developments

Table 172. Hikma Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 173. Hikma Pharmaceuticals Oxcarbazepine Product Offered

Table 174. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Hikma Pharmaceuticals Main Business

Table 176. Hikma Pharmaceuticals Latest Developments

Table 177. Jamp Pharma Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 178. Jamp Pharma Oxcarbazepine Product Offered

Table 179. Jamp Pharma Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Jamp Pharma Main Business

Table 181. Jamp Pharma Latest Developments

Table 182. Neuraxpharm Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 183. Neuraxpharm Oxcarbazepine Product Offered

Table 184. Neuraxpharm Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Neuraxpharm Main Business

Table 186. Neuraxpharm Latest Developments

Table 187. Orion Corporation Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 188. Orion Corporation Oxcarbazepine Product Offered

Table 189. Orion Corporation Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Orion Corporation Main Business

Table 191. Orion Corporation Latest Developments

Table 192. Sihuan Pharm Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 193. Sihuan Pharm Oxcarbazepine Product Offered

Table 194. Sihuan Pharm Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 195. Sihuan Pharm Main Business

Table 196. Sihuan Pharm Latest Developments

Table 197. Humanwell Healthcare Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 198. Humanwell Healthcare Oxcarbazepine Product Offered

Table 199. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 200. Humanwell Healthcare Main Business

Table 201. Humanwell Healthcare Latest Developments

Table 202. Huikang Pharmaceutical Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors

Table 203. Huikang Pharmaceutical Oxcarbazepine Product Offered

Table 204. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 205. Huikang Pharmaceutical Main Business

Table 206. Huikang Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Oxcarbazepine

Figure 2. Oxcarbazepine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oxcarbazepine Sales Growth Rate 2017-2028 (M Unit)

Figure 7. Global Oxcarbazepine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oxcarbazepine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets (150mg, 300mg, 600mg)

Figure 10. Product Picture of Oral Suspension

Figure 11. Global Oxcarbazepine Sales Market Share by Type in 2021

Figure 12. Global Oxcarbazepine Revenue Market Share by Type (2017-2022)

Figure 13. Oxcarbazepine Consumed in Pediatric Use (Aged 2-4 years, 4-16 years)

Figure 14. Global Oxcarbazepine Market: Pediatric Use (Aged 2-4 years, 4-16 years) (2017-2022) & (M Unit)

Figure 15. Oxcarbazepine Consumed in Adult Use

Figure 16. Global Oxcarbazepine Market: Adult Use (2017-2022) & (M Unit)

Figure 17. Global Oxcarbazepine Sales Market Share by Application (2017-2022)

Figure 18. Global Oxcarbazepine Revenue Market Share by Application in 2021

Figure 19. Oxcarbazepine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Oxcarbazepine Revenue Market Share by Company in 2021

Figure 21. Global Oxcarbazepine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Oxcarbazepine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Oxcarbazepine Sales Market Share by Region (2017-2022)

Figure 24. Global Oxcarbazepine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Oxcarbazepine Sales 2017-2022 (M Unit)

Figure 26. Americas Oxcarbazepine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Oxcarbazepine Sales 2017-2022 (M Unit)

Figure 28. APAC Oxcarbazepine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Oxcarbazepine Sales 2017-2022 (M Unit)

Figure 30. Europe Oxcarbazepine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Oxcarbazepine Sales 2017-2022 (M Unit)

Figure 32. Middle East & Africa Oxcarbazepine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Oxcarbazepine Sales Market Share by Country in 2021

Figure 34. Americas Oxcarbazepine Revenue Market Share by Country in 2021

Figure 35. United States Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Oxcarbazepine Sales Market Share by Region in 2021

Figure 40. APAC Oxcarbazepine Revenue Market Share by Regions in 2021

Figure 41. China Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Oxcarbazepine Sales Market Share by Country in 2021

Figure 48. Europe Oxcarbazepine Revenue Market Share by Country in 2021

Figure 49. Germany Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Oxcarbazepine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Oxcarbazepine Revenue Market Share by Country in 2021

Figure 56. Egypt Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Oxcarbazepine in 2021

Figure 62. Manufacturing Process Analysis of Oxcarbazepine

Figure 63. Industry Chain Structure of Oxcarbazepine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles